For the latest ecancer COVID-19 resources, click on this link

Breast

Prostate & urology

Lung & pleura

Colorectal & gastro

Melanoma & skin

Head & neck

Ovary & gynaecology

+ -

The Institute of Cancer Research, Sutton, UK

ESMO 33

12 - 16 Sep 2008

Published: 28 Nov 2008

Views: 15091

Rating:

Save

Prof. Alan Horwich

Incidence of contralateral germ cell tumours, from ESMO 2008

Related Videos

Bevacizumab-induced hypertension and proteinuria: A genome-wide analysis of more...

Prof Federico Innocenti - University of North Carolina, Chapel Hill, USA

Bevacizumab-induced hypertension and proteinuria: A genome-wide analysis of more than 1,000 patients ( Prof Federico Innocenti - University of North Carolina, Chapel Hill, USA )

IMvigor130: Atezolizumab with or without chemotherapy in metastatic urothelial c...

Prof Matthew Galsky - The Mount Sinai Hospital, New York, USA

IMvigor130: Atezolizumab with or without chemotherapy in metastatic urothelial cancer ( Prof Matthew Galsky - The Mount Sinai Hospital, New York, USA )

Prostate cancer patients receiving androgen-deprivation therapies shown to be at...

Prof Andrea Alimonti - Università della Svizzera Italiana, Bellinzona, Switzerla...

Prostate cancer patients receiving androgen-deprivation therapies shown to be at lower risk from COVID-19 ( Prof Andrea Alimonti - Università della Svizzera Italiana, Bellinzona, Switzerland )

Revolutionising imaging with PSMA PET in prostate cancer

Dr Bernard Henk-Erik Jansen - VU University Medical Center, Amsterdam, The Nethe...

Revolutionising imaging with PSMA PET in prostate cancer ( Dr Bernard Henk-Erik Jansen - VU University Medical Center, Amsterdam, The Netherlands )

Over-diagnosis of low-grade prostate cancer, good or bad?

Prof Hendrik Van Poppel - KU Leuven, Leuven, Belgium

Over-diagnosis of low-grade prostate cancer, good or bad? ( Prof Hendrik Van Poppel - KU Leuven, Leuven, Belgium )

PRIAS: Active surveillance for men with low risk prostate cancer

Prof Monique J. Roobol - Erasmus University Medical Center, Rotterdam, The Nethe...

PRIAS: Active surveillance for men with low risk prostate cancer ( Prof Monique J. Roobol - Erasmus University Medical Center, Rotterdam, The Netherlands )

Where have we got to with cancer treatment?

Prof Alexander Eggermont - Princess Máxima Center for Pediatric Oncology, Utrech...

Where have we got to with cancer treatment? ( Prof Alexander Eggermont - Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands )

CARD: Cabazitaxel vs abiraterone or enzalutamide in metastatic castration-resist...

Prof Ronald de Wit - Erasmus University Medical Center, Rotterdam, Netherlands

CARD: Cabazitaxel vs abiraterone or enzalutamide in metastatic castration-resistant prostate cancer ( Prof Ronald de Wit - Erasmus University Medical Center, Rotterdam, Netherlands )

TRITON2: Rucaparib for metastatic castration-resistant prostate cancer

Prof Ray McDermott - St. Vincents University Hospital, Dublin, Republic of Irela...

TRITON2: Rucaparib for metastatic castration-resistant prostate cancer ( Prof Ray McDermott - St. Vincents University Hospital, Dublin, Republic of Ireland )

More from ecancer